{"id": "article-19266_0", "title": "Cetirizine -- Continuing Education Activity", "content": "This activity discusses\u00a0using cetirizine for allergic rhinitis and urticaria, shedding light on its indications, mechanism of action, and contraindications. Initially approved by the FDA in 1995 as a prescription-only medication, cetirizine gained over-the-counter status in 2007. This\u00a0discussion also\u00a0navigates the adverse event profile and other critical aspects, including\u00a0off-label uses, dosing, pharmacokinetics, monitoring, and relevant drug interactions, highlighting the role of the interprofessional healthcare team in overseeing therapy. Understanding cetirizine's\u00a0pharmacology empowers healthcare professionals to tailor treatment plans to individual patient needs. Equipped with evidence-based medicine, they can make informed decisions and fine-tune dosage regimens while mitigating adverse reactions.\u00a0By enhancing comprehension of cetirizine's pharmacological nuances, this educational initiative aims to elevate patient outcomes in allergic conditions, emphasizing the collaborative effort of the healthcare team in optimizing treatment strategies.", "contents": "Cetirizine -- Continuing Education Activity. This activity discusses\u00a0using cetirizine for allergic rhinitis and urticaria, shedding light on its indications, mechanism of action, and contraindications. Initially approved by the FDA in 1995 as a prescription-only medication, cetirizine gained over-the-counter status in 2007. This\u00a0discussion also\u00a0navigates the adverse event profile and other critical aspects, including\u00a0off-label uses, dosing, pharmacokinetics, monitoring, and relevant drug interactions, highlighting the role of the interprofessional healthcare team in overseeing therapy. Understanding cetirizine's\u00a0pharmacology empowers healthcare professionals to tailor treatment plans to individual patient needs. Equipped with evidence-based medicine, they can make informed decisions and fine-tune dosage regimens while mitigating adverse reactions.\u00a0By enhancing comprehension of cetirizine's pharmacological nuances, this educational initiative aims to elevate patient outcomes in allergic conditions, emphasizing the collaborative effort of the healthcare team in optimizing treatment strategies."}
{"id": "article-19266_1", "title": "Cetirizine -- Continuing Education Activity", "content": "Objectives: Identify\u00a0the mechanism of action of cetirizine. Evaluate\u00a0the adverse effects of cetirizine. Assess\u00a0the clinical monitoring parameters\u00a0for\u00a0cetirizine. Implement effective collaboration and communication among interprofessional team members to improve patient outcomes and treatment efficacy while educating about potential adverse effects of cetirizine, such as drowsiness and fatigue. Access free multiple choice questions on this topic.", "contents": "Cetirizine -- Continuing Education Activity. Objectives: Identify\u00a0the mechanism of action of cetirizine. Evaluate\u00a0the adverse effects of cetirizine. Assess\u00a0the clinical monitoring parameters\u00a0for\u00a0cetirizine. Implement effective collaboration and communication among interprofessional team members to improve patient outcomes and treatment efficacy while educating about potential adverse effects of cetirizine, such as drowsiness and fatigue. Access free multiple choice questions on this topic."}
{"id": "article-19266_2", "title": "Cetirizine -- Indications", "content": "Cetirizine was FDA-approved in the United States as a prescription-only\u00a0product in 1995.\u00a0In 2007, it\u00a0was approved as an over-the-counter medication. Derived from the first-generation antihistamine hydroxyzine, cetirizine does not cross the blood-brain barrier to the extent of its first-generation counterparts. As a result, cetirizine is an effective treatment of allergic rhinitis that simultaneously minimizes the possibility of adverse sedative effects. In addition, cetirizine is a second-generation antihistamine that effectively relieves sneezing, rhinorrhea, and watery eyes associated with seasonal allergies and allergic rhinitis due to allergens such as dust mites and molds.\u00a0Additionally, cetirizine is available as a prescription-only ophthalmic formulation to treat allergic conjunctivitis.", "contents": "Cetirizine -- Indications. Cetirizine was FDA-approved in the United States as a prescription-only\u00a0product in 1995.\u00a0In 2007, it\u00a0was approved as an over-the-counter medication. Derived from the first-generation antihistamine hydroxyzine, cetirizine does not cross the blood-brain barrier to the extent of its first-generation counterparts. As a result, cetirizine is an effective treatment of allergic rhinitis that simultaneously minimizes the possibility of adverse sedative effects. In addition, cetirizine is a second-generation antihistamine that effectively relieves sneezing, rhinorrhea, and watery eyes associated with seasonal allergies and allergic rhinitis due to allergens such as dust mites and molds.\u00a0Additionally, cetirizine is available as a prescription-only ophthalmic formulation to treat allergic conjunctivitis."}
{"id": "article-19266_3", "title": "Cetirizine -- Indications -- FDA-Approved Indications", "content": "Cetirizine is an FDA-approved medication for the relief and treatment of allergic rhinitis and chronic urticaria. [1] [2] The American Academy of Otolaryngology\u00a0suggests\u00a0cetirizine for seasonal and perennial allergic rhinitis. [3] Cetirizine effectively reduces the severity of hives and pruritus in patients with idiopathic urticaria. [4] Second-generation antihistamines like cetirizine are safe and effective\u00a0treatment options\u00a0in patients with\u00a0chronic urticaria\u00a0and are considered first-line agents by the\u00a0AAAAI and\u00a0ACAAI guidelines. [5] Cetirizine is considered safe for\u00a0perennial allergic rhinitis and urticaria in adults and children\u00a0older than 6 months; it is indicated for treating seasonal allergies in adults and children\u00a02 years and older. The ophthalmic formulation of cetirizine is FDA-approved to treat allergic conjunctivitis. [6] The FDA has approved the intravenous formulation of cetirizine for treating acute urticaria. [7]", "contents": "Cetirizine -- Indications -- FDA-Approved Indications. Cetirizine is an FDA-approved medication for the relief and treatment of allergic rhinitis and chronic urticaria. [1] [2] The American Academy of Otolaryngology\u00a0suggests\u00a0cetirizine for seasonal and perennial allergic rhinitis. [3] Cetirizine effectively reduces the severity of hives and pruritus in patients with idiopathic urticaria. [4] Second-generation antihistamines like cetirizine are safe and effective\u00a0treatment options\u00a0in patients with\u00a0chronic urticaria\u00a0and are considered first-line agents by the\u00a0AAAAI and\u00a0ACAAI guidelines. [5] Cetirizine is considered safe for\u00a0perennial allergic rhinitis and urticaria in adults and children\u00a0older than 6 months; it is indicated for treating seasonal allergies in adults and children\u00a02 years and older. The ophthalmic formulation of cetirizine is FDA-approved to treat allergic conjunctivitis. [6] The FDA has approved the intravenous formulation of cetirizine for treating acute urticaria. [7]"}
{"id": "article-19266_4", "title": "Cetirizine -- Indications -- Off-Label Uses", "content": "Cetirizine is used as an adjunct to epinephrine (off-label) for the management of anaphylaxis. (The American Academy of Allergy, Asthma & Immunology (AAAAI) and the American College of Allergy, Asthma\u00a0& Immunology (ACAAI) guidelines). [8] Cetirizine is effective in infusion-related reactions due\u00a0to ocrelizumab\u00a0and non-inferior to diphenhydramine. [9] Research has demonstrated the efficacy of cetirizine as a premedication agent for preventing hypersensitivity reactions induced by chemotherapy. [10] BASCULE syndrome is characterized by Bier anemic spots, cyanosis, and urticaria-like eruption.\u00a0In a retrospective chart review of\u00a0patients with BASCULE syndrome, treatment responses to propranolol and high-dose cetirizine were noted. [11] A recent study suggests that topical cetirizine 1%\u00a0could be a potential treatment for androgenic alopecia,\u00a0especially for individuals who show poor responsiveness to topical minoxidil. Further\u00a0research\u00a0is needed to confirm these findings. [12]", "contents": "Cetirizine -- Indications -- Off-Label Uses. Cetirizine is used as an adjunct to epinephrine (off-label) for the management of anaphylaxis. (The American Academy of Allergy, Asthma & Immunology (AAAAI) and the American College of Allergy, Asthma\u00a0& Immunology (ACAAI) guidelines). [8] Cetirizine is effective in infusion-related reactions due\u00a0to ocrelizumab\u00a0and non-inferior to diphenhydramine. [9] Research has demonstrated the efficacy of cetirizine as a premedication agent for preventing hypersensitivity reactions induced by chemotherapy. [10] BASCULE syndrome is characterized by Bier anemic spots, cyanosis, and urticaria-like eruption.\u00a0In a retrospective chart review of\u00a0patients with BASCULE syndrome, treatment responses to propranolol and high-dose cetirizine were noted. [11] A recent study suggests that topical cetirizine 1%\u00a0could be a potential treatment for androgenic alopecia,\u00a0especially for individuals who show poor responsiveness to topical minoxidil. Further\u00a0research\u00a0is needed to confirm these findings. [12]"}
{"id": "article-19266_5", "title": "Cetirizine -- Mechanism of Action", "content": "Cetirizine is a fast-acting, highly selective peripheral histamine H1-receptor antagonist. The H1-receptors inhibited by cetirizine are primarily on respiratory smooth muscle cells, vascular endothelial cells, immune cells, and the gastrointestinal tract. Unlike first-generation antihistamines such as diphenhydramine and doxylamine, cetirizine does not cross the blood-brain barrier to a large extent, avoiding the neurons of the central nervous system. As a result, cetirizine produces minimal sedation compared to many first-generation antihistamines. [13]", "contents": "Cetirizine -- Mechanism of Action. Cetirizine is a fast-acting, highly selective peripheral histamine H1-receptor antagonist. The H1-receptors inhibited by cetirizine are primarily on respiratory smooth muscle cells, vascular endothelial cells, immune cells, and the gastrointestinal tract. Unlike first-generation antihistamines such as diphenhydramine and doxylamine, cetirizine does not cross the blood-brain barrier to a large extent, avoiding the neurons of the central nervous system. As a result, cetirizine produces minimal sedation compared to many first-generation antihistamines. [13]"}
{"id": "article-19266_6", "title": "Cetirizine -- Mechanism of Action", "content": "Given its antagonism with histamine H1-receptors, cetirizine effectively reverses many of the effects of histamine. Like other second-generation antihistamines, cetirizine decreases vascular permeability, decreasing fluid escaping to tissues from capillaries. Cetirizine is also an inhibitor of histamine-induced bronchospasm. [14]", "contents": "Cetirizine -- Mechanism of Action. Given its antagonism with histamine H1-receptors, cetirizine effectively reverses many of the effects of histamine. Like other second-generation antihistamines, cetirizine decreases vascular permeability, decreasing fluid escaping to tissues from capillaries. Cetirizine is also an inhibitor of histamine-induced bronchospasm. [14]"}
{"id": "article-19266_7", "title": "Cetirizine -- Mechanism of Action", "content": "Cetirizine has\u00a0demonstrated significant anti-inflammatory activity, reducing the infiltration of inflammatory cells in allergic rhinitis. [15] Specifically, research has found that cetirizine minimizes the migration of neutrophils and eosinophils. [16]", "contents": "Cetirizine -- Mechanism of Action. Cetirizine has\u00a0demonstrated significant anti-inflammatory activity, reducing the infiltration of inflammatory cells in allergic rhinitis. [15] Specifically, research has found that cetirizine minimizes the migration of neutrophils and eosinophils. [16]"}
{"id": "article-19266_8", "title": "Cetirizine -- Mechanism of Action -- Pharmacokinetics", "content": "Absorption: Cetirizine is absorbed rapidly in the gastrointestinal tract and undergoes substantial excretion by the kidney. Cetirizine reaches peak plasma concentration after approximately\u00a01 hour. The effects of cetirizine typically begin after 20 to 60 minutes and persist for at least 24 hours. Food does not affect\u00a0the extent of exposure (AUC) of cetirizine, but the time to attain peak concentration\u00a0is delayed by 1.7 hours. Distribution: The mean plasma protein binding of cetirizine is 93%.", "contents": "Cetirizine -- Mechanism of Action -- Pharmacokinetics. Absorption: Cetirizine is absorbed rapidly in the gastrointestinal tract and undergoes substantial excretion by the kidney. Cetirizine reaches peak plasma concentration after approximately\u00a01 hour. The effects of cetirizine typically begin after 20 to 60 minutes and persist for at least 24 hours. Food does not affect\u00a0the extent of exposure (AUC) of cetirizine, but the time to attain peak concentration\u00a0is delayed by 1.7 hours. Distribution: The mean plasma protein binding of cetirizine is 93%."}
{"id": "article-19266_9", "title": "Cetirizine -- Mechanism of Action -- Pharmacokinetics", "content": "Metabolism: Cetirizine undergoes oxidative O-dealkylation to a metabolite with negligible antihistaminic activity. Cetirizine is not a\u00a0substrate of the CYP450 system. [17] [18] Evidence indicates that cetirizine\u00a0is a P-glycoprotein substrate, which should be\u00a0considered in patients using cetirizine\u00a0concurrently with P-gp\u00a0inhibitors. [19] Excretion: The elimination half-life of cetirizine\u00a0is 8.3 hours. Cetirizine\u00a0is primarily excreted through\u00a0the kidney. [20]", "contents": "Cetirizine -- Mechanism of Action -- Pharmacokinetics. Metabolism: Cetirizine undergoes oxidative O-dealkylation to a metabolite with negligible antihistaminic activity. Cetirizine is not a\u00a0substrate of the CYP450 system. [17] [18] Evidence indicates that cetirizine\u00a0is a P-glycoprotein substrate, which should be\u00a0considered in patients using cetirizine\u00a0concurrently with P-gp\u00a0inhibitors. [19] Excretion: The elimination half-life of cetirizine\u00a0is 8.3 hours. Cetirizine\u00a0is primarily excreted through\u00a0the kidney. [20]"}
{"id": "article-19266_10", "title": "Cetirizine -- Administration -- Available Dosage Forms and Strengths", "content": "Cetirizine is available as oral tablets, capsules,\u00a0solutions, and orally disintegrating tablets. The dosing of cetirizine depends on the patient's age. In adults and children 12 years or older, the recommended dose is 5 to 10 mg/d orally, depending on symptom severity. [21] Cetirizine is available in 5 mg and 10 mg tablets and 5 mg/5 mL oral solution and elixir. The ophthalmic formulation is 0.24% cetirizine hydrochloride eye drops in 5 mL and 7.5 mL bottles.\u00a0Cetirizine 5 mg combined with pseudoephedrine HCl 120 mg is a nasal decongestant that temporarily relieves sinus congestion and pressure.", "contents": "Cetirizine -- Administration -- Available Dosage Forms and Strengths. Cetirizine is available as oral tablets, capsules,\u00a0solutions, and orally disintegrating tablets. The dosing of cetirizine depends on the patient's age. In adults and children 12 years or older, the recommended dose is 5 to 10 mg/d orally, depending on symptom severity. [21] Cetirizine is available in 5 mg and 10 mg tablets and 5 mg/5 mL oral solution and elixir. The ophthalmic formulation is 0.24% cetirizine hydrochloride eye drops in 5 mL and 7.5 mL bottles.\u00a0Cetirizine 5 mg combined with pseudoephedrine HCl 120 mg is a nasal decongestant that temporarily relieves sinus congestion and pressure."}
{"id": "article-19266_11", "title": "Cetirizine -- Administration -- Available Dosage Forms and Strengths", "content": "Children 6 to 11 years old: 5 to 10 mg (1 or 2 teaspoons) once daily in syrup form is recommended, depending on symptom severity. [22] Children 2 to 5 years old: 2.5 mg (half a teaspoon) in syrup form once daily. Children\u00a06 months to 23 months old: the recommended dose is 2.5 mg (half teaspoon) in syrup form once daily. One drop (0.24% cetirizine hydrochloride ophthalmic solution) is instilled in the affected eye twice daily for patients with allergic conjunctivitis. The FDA has approved the IV\u00a0administration of cetirizine 10 mg to treat acute urticaria in adults and adolescents aged 12 and older.", "contents": "Cetirizine -- Administration -- Available Dosage Forms and Strengths. Children 6 to 11 years old: 5 to 10 mg (1 or 2 teaspoons) once daily in syrup form is recommended, depending on symptom severity. [22] Children 2 to 5 years old: 2.5 mg (half a teaspoon) in syrup form once daily. Children\u00a06 months to 23 months old: the recommended dose is 2.5 mg (half teaspoon) in syrup form once daily. One drop (0.24% cetirizine hydrochloride ophthalmic solution) is instilled in the affected eye twice daily for patients with allergic conjunctivitis. The FDA has approved the IV\u00a0administration of cetirizine 10 mg to treat acute urticaria in adults and adolescents aged 12 and older."}
{"id": "article-19266_12", "title": "Cetirizine -- Administration -- Use in Specific Patient Population", "content": "Breastfeeding Considerations: Occasional and small doses of cetirizine are acceptable while breastfeeding. Prolonged use of larger doses may cause a decrease in the milk supply or drowsiness and other adverse effects in the infant, particularly when combined with pseudoephedrine. The use of an ophthalmic formulation of cetirizine by the mother\u00a0is\u00a0thought to\u00a0have minimal\u00a0risk to the breastfed infant. Clinicians should advise the mother to apply pressure over the tear duct by the corner of the eye and remove the leftover solution to\u00a0decrease the drug that reaches the breast milk. [23]", "contents": "Cetirizine -- Administration -- Use in Specific Patient Population. Breastfeeding Considerations: Occasional and small doses of cetirizine are acceptable while breastfeeding. Prolonged use of larger doses may cause a decrease in the milk supply or drowsiness and other adverse effects in the infant, particularly when combined with pseudoephedrine. The use of an ophthalmic formulation of cetirizine by the mother\u00a0is\u00a0thought to\u00a0have minimal\u00a0risk to the breastfed infant. Clinicians should advise the mother to apply pressure over the tear duct by the corner of the eye and remove the leftover solution to\u00a0decrease the drug that reaches the breast milk. [23]"}
{"id": "article-19266_13", "title": "Cetirizine -- Administration -- Use in Specific Patient Population", "content": "Pregnancy Considerations: Cetirizine\u00a0is a former U.S. FDA pregnancy category B medicine.  The American College of Obstetricians and Gynecologists and the American College of Allergy, Asthma, and Immunology (ACOG-ACAAI)\u00a0recommend cetirizine for pregnant women who require antihistamine treatment.\u00a0Cetirizine should be used in pregnancy only when necessary. [24] [25]", "contents": "Cetirizine -- Administration -- Use in Specific Patient Population. Pregnancy Considerations: Cetirizine\u00a0is a former U.S. FDA pregnancy category B medicine.  The American College of Obstetricians and Gynecologists and the American College of Allergy, Asthma, and Immunology (ACOG-ACAAI)\u00a0recommend cetirizine for pregnant women who require antihistamine treatment.\u00a0Cetirizine should be used in pregnancy only when necessary. [24] [25]"}
{"id": "article-19266_14", "title": "Cetirizine -- Administration -- Use in Specific Patient Population", "content": "Hepatic Impairment: According to the manufacturer's prescribing information, the dose for 12-year-old and older patients with hepatic impairment should be reduced to 5 mg daily. The manufacturer also recommends lowering the dose for patients 6 to 11 years old with hepatic impairment.\u00a0Intravenous\u00a0administration of cetirizine is intended for short-term use; no dose adjustment is required per the manufacturer's labeling.", "contents": "Cetirizine -- Administration -- Use in Specific Patient Population. Hepatic Impairment: According to the manufacturer's prescribing information, the dose for 12-year-old and older patients with hepatic impairment should be reduced to 5 mg daily. The manufacturer also recommends lowering the dose for patients 6 to 11 years old with hepatic impairment.\u00a0Intravenous\u00a0administration of cetirizine is intended for short-term use; no dose adjustment is required per the manufacturer's labeling."}
{"id": "article-19266_15", "title": "Cetirizine -- Administration -- Use in Specific Patient Population", "content": "Renal Impairment: Manufacturers' prescribing information suggests reducing the dose to 5 mg daily for patients aged 12 years and older with decreased renal function (CrCL 11 to 31 mL/min) and patients on hemodialysis. The manufacturer also recommends lowering the dose for 6 to\u00a011-year-old patients with renal impairment. The IV formulation of cetirizine is intended for short-term use; no dose adjustment is required per the manufacturer's labeling.", "contents": "Cetirizine -- Administration -- Use in Specific Patient Population. Renal Impairment: Manufacturers' prescribing information suggests reducing the dose to 5 mg daily for patients aged 12 years and older with decreased renal function (CrCL 11 to 31 mL/min) and patients on hemodialysis. The manufacturer also recommends lowering the dose for 6 to\u00a011-year-old patients with renal impairment. The IV formulation of cetirizine is intended for short-term use; no dose adjustment is required per the manufacturer's labeling."}
{"id": "article-19266_16", "title": "Cetirizine -- Administration -- Use in Specific Patient Population", "content": "Pediatric Patients: According to one meta-analysis, there is moderate to low certainty evidence that cetirizine may improve clinical outcomes and quality of life in children with allergic rhinitis. Cetirizine\u00a0demonstrates\u00a0comparable efficacy with other antihistamines and is generally well tolerated, although there is an increased risk of somnolence in the pediatric population. [26] The intravenous formulation is FDA-approved for urticaria in children 6 months and older.\u00a0For adolescents aged 12 years and older, the recommended intravenous dosage of cetirizine is 10 mg. Children aged 6 to 11 years old may receive either 5 mg to 10 mg, depending on symptom severity. For children aged 6 months to 5 years, the recommended intravenous dosage is 2.5 mg.", "contents": "Cetirizine -- Administration -- Use in Specific Patient Population. Pediatric Patients: According to one meta-analysis, there is moderate to low certainty evidence that cetirizine may improve clinical outcomes and quality of life in children with allergic rhinitis. Cetirizine\u00a0demonstrates\u00a0comparable efficacy with other antihistamines and is generally well tolerated, although there is an increased risk of somnolence in the pediatric population. [26] The intravenous formulation is FDA-approved for urticaria in children 6 months and older.\u00a0For adolescents aged 12 years and older, the recommended intravenous dosage of cetirizine is 10 mg. Children aged 6 to 11 years old may receive either 5 mg to 10 mg, depending on symptom severity. For children aged 6 months to 5 years, the recommended intravenous dosage is 2.5 mg."}
{"id": "article-19266_17", "title": "Cetirizine -- Administration -- Use in Specific Patient Population", "content": "Older Patients: Efficacy evaluations did not include an adequate number of patients aged 65 years and older to determine potential divergent response patterns compared to younger patients. Safety assessments of cetirizine in older patients compared to younger\u00a0adults\u00a0revealed no significant differences. However, sensitivity to adverse drug reactions in certain older individuals remains a possibility.", "contents": "Cetirizine -- Administration -- Use in Specific Patient Population. Older Patients: Efficacy evaluations did not include an adequate number of patients aged 65 years and older to determine potential divergent response patterns compared to younger patients. Safety assessments of cetirizine in older patients compared to younger\u00a0adults\u00a0revealed no significant differences. However, sensitivity to adverse drug reactions in certain older individuals remains a possibility."}
{"id": "article-19266_18", "title": "Cetirizine -- Administration -- Use in Specific Patient Population", "content": "Ophthalmic Formulation: Each bottle of 0.24% cetirizine hydrochloride contains benzalkonium chloride and can be absorbed by contact lenses. Manufacturers advise patients to remove contact lenses and wait 10 minutes after administration until the reinsertion of lenses. If irritation or redness persists after this precaution, contact lenses should be avoided.\u00a0Cetirizine has proven safe and effective for pediatric patients\u00a02 years and\u00a0older in clinical studies. [27]", "contents": "Cetirizine -- Administration -- Use in Specific Patient Population. Ophthalmic Formulation: Each bottle of 0.24% cetirizine hydrochloride contains benzalkonium chloride and can be absorbed by contact lenses. Manufacturers advise patients to remove contact lenses and wait 10 minutes after administration until the reinsertion of lenses. If irritation or redness persists after this precaution, contact lenses should be avoided.\u00a0Cetirizine has proven safe and effective for pediatric patients\u00a02 years and\u00a0older in clinical studies. [27]"}
{"id": "article-19266_19", "title": "Cetirizine -- Adverse Effects", "content": "Cetirizine is safe and relatively well-tolerated for treating allergic rhinitis and urticaria. Although uncommon, its primary adverse effects in adults include somnolence, fatigue, pharyngitis, dizziness, and dry mouth. [1] Somnolence appears to be a dose-related effect of cetirizine. Research indicates that in some patients, cetirizine contributes to daytime sleepiness. [28]", "contents": "Cetirizine -- Adverse Effects. Cetirizine is safe and relatively well-tolerated for treating allergic rhinitis and urticaria. Although uncommon, its primary adverse effects in adults include somnolence, fatigue, pharyngitis, dizziness, and dry mouth. [1] Somnolence appears to be a dose-related effect of cetirizine. Research indicates that in some patients, cetirizine contributes to daytime sleepiness. [28]"}
{"id": "article-19266_20", "title": "Cetirizine -- Adverse Effects", "content": "Children taking cetirizine\u00a0most commonly experience similar side effects as adults taking cetirizine (eg, somnolence, fatigue, and dry mouth). Children, in particular, are more likely than adults to experience headaches while taking cetirizine. [29]", "contents": "Cetirizine -- Adverse Effects. Children taking cetirizine\u00a0most commonly experience similar side effects as adults taking cetirizine (eg, somnolence, fatigue, and dry mouth). Children, in particular, are more likely than adults to experience headaches while taking cetirizine. [29]"}
{"id": "article-19266_21", "title": "Cetirizine -- Adverse Effects", "content": "In pediatric patients aged 2 to 11, the majority of adverse reactions reported with cetirizine were mild or moderate. Somnolence appeared to be dose-related, and\u00a0abdominal pain was considered treatment-related. Common\u00a0adverse drug reactions of cetirizine ophthalmic solution are conjunctival hyperemia and instillation site pain. [6]", "contents": "Cetirizine -- Adverse Effects. In pediatric patients aged 2 to 11, the majority of adverse reactions reported with cetirizine were mild or moderate. Somnolence appeared to be dose-related, and\u00a0abdominal pain was considered treatment-related. Common\u00a0adverse drug reactions of cetirizine ophthalmic solution are conjunctival hyperemia and instillation site pain. [6]"}
{"id": "article-19266_22", "title": "Cetirizine -- Adverse Effects", "content": "A few cases of transient, reversible hepatic transaminase elevations\u00a0during cetirizine therapy have been reported in the literature. Some reports of hepatitis with elevated bilirubin have also been documented. In postmarketing studies, rare, potentially severe adverse events, including severe hypotension, anaphylaxis, hemolytic anemia, cholestasis, orofacial dyskinesia, glomerulonephritis, hepatitis, stillbirth, and thrombocytopenia,\u00a0have been reported. [30] The most common adverse reactions to ophthalmic formulations\u00a0include local pain at the instillation site, ocular hyperemia, and decreased visual acuity.", "contents": "Cetirizine -- Adverse Effects. A few cases of transient, reversible hepatic transaminase elevations\u00a0during cetirizine therapy have been reported in the literature. Some reports of hepatitis with elevated bilirubin have also been documented. In postmarketing studies, rare, potentially severe adverse events, including severe hypotension, anaphylaxis, hemolytic anemia, cholestasis, orofacial dyskinesia, glomerulonephritis, hepatitis, stillbirth, and thrombocytopenia,\u00a0have been reported. [30] The most common adverse reactions to ophthalmic formulations\u00a0include local pain at the instillation site, ocular hyperemia, and decreased visual acuity."}
{"id": "article-19266_23", "title": "Cetirizine -- Adverse Effects -- Drug-Drug Interactions", "content": "Patients should\u00a0be advised not to use cetirizine concurrently with alcohol or other CNS\u00a0depressants, such as benzodiazepines or opioids, as\u00a0this combination may\u00a0result in dose-related sedation. [31] Pitolisant is a histamine-3 receptor competitive antagonist and inverse agonist used in patients with narcolepsy. Concurrent use with antihistamines like cetirizine may diminish the therapeutic efficacy of pitolisant.\u00a0This combination should be avoided. [32] Cetirizine\u00a0decreases\u00a0gabapentin plasma concentrations and\u00a0reduces systemic exposure to gabapentin. However, gabapentin is a CNS depressant. Pharmacodynamic synergism between these 2 drugs may lead to additional and observable CNS depression. [33] Cetirizine is a substrate of\u00a0P-glycoprotein, and verapamil is an inhibitor of P-glycoprotein. Concurrent administration of both drugs\u00a0prevents the efflux of cetirizine from the CNS and increases antihistaminic activity. [19]", "contents": "Cetirizine -- Adverse Effects -- Drug-Drug Interactions. Patients should\u00a0be advised not to use cetirizine concurrently with alcohol or other CNS\u00a0depressants, such as benzodiazepines or opioids, as\u00a0this combination may\u00a0result in dose-related sedation. [31] Pitolisant is a histamine-3 receptor competitive antagonist and inverse agonist used in patients with narcolepsy. Concurrent use with antihistamines like cetirizine may diminish the therapeutic efficacy of pitolisant.\u00a0This combination should be avoided. [32] Cetirizine\u00a0decreases\u00a0gabapentin plasma concentrations and\u00a0reduces systemic exposure to gabapentin. However, gabapentin is a CNS depressant. Pharmacodynamic synergism between these 2 drugs may lead to additional and observable CNS depression. [33] Cetirizine is a substrate of\u00a0P-glycoprotein, and verapamil is an inhibitor of P-glycoprotein. Concurrent administration of both drugs\u00a0prevents the efflux of cetirizine from the CNS and increases antihistaminic activity. [19]"}
{"id": "article-19266_24", "title": "Cetirizine -- Adverse Effects", "content": "Cetirizine should not be administered with erdafitinib, an inhibitor of P-glycoprotein (ABCB1, MDR1). [34]", "contents": "Cetirizine -- Adverse Effects. Cetirizine should not be administered with erdafitinib, an inhibitor of P-glycoprotein (ABCB1, MDR1). [34]"}
{"id": "article-19266_25", "title": "Cetirizine -- Contraindications", "content": "Cetirizine is contraindicated in\u00a0patients with a known hypersensitivity to it or any of its ingredients. Cetirizine is also contraindicated in anyone with a known hypersensitivity to hydroxyzine, as cetirizine is a metabolite of hydroxyzine. [35]", "contents": "Cetirizine -- Contraindications. Cetirizine is contraindicated in\u00a0patients with a known hypersensitivity to it or any of its ingredients. Cetirizine is also contraindicated in anyone with a known hypersensitivity to hydroxyzine, as cetirizine is a metabolite of hydroxyzine. [35]"}
{"id": "article-19266_26", "title": "Cetirizine -- Contraindications -- Warnings and Precautions", "content": "There are few well-controlled human studies on cetirizine in pregnant mothers, although these showed it to be safe during pregnancy in animal studies. First-generation antihistamines, diphenhydramine, and doxylamine are safest to use during pregnancy.\u00a0However, first-generation antihistamines are more likely than second-generation antihistamines to cause somnolence; clinicians should counsel the patients regarding the potential adverse effects of the medication they choose to take during pregnancy. [24]", "contents": "Cetirizine -- Contraindications -- Warnings and Precautions. There are few well-controlled human studies on cetirizine in pregnant mothers, although these showed it to be safe during pregnancy in animal studies. First-generation antihistamines, diphenhydramine, and doxylamine are safest to use during pregnancy.\u00a0However, first-generation antihistamines are more likely than second-generation antihistamines to cause somnolence; clinicians should counsel the patients regarding the potential adverse effects of the medication they choose to take during pregnancy. [24]"}
{"id": "article-19266_27", "title": "Cetirizine -- Monitoring", "content": "Patients taking cetirizine require monitoring for the relief of symptoms.\u00a0Healthcare team members\u00a0should also monitor patients for adverse effects such as fatigue and somnolence in adults and headaches in children.", "contents": "Cetirizine -- Monitoring. Patients taking cetirizine require monitoring for the relief of symptoms.\u00a0Healthcare team members\u00a0should also monitor patients for adverse effects such as fatigue and somnolence in adults and headaches in children."}
{"id": "article-19266_28", "title": "Cetirizine -- Monitoring", "content": "The kidney primarily excretes cetirizine; as a result, the risk of toxicity is typically higher in patients with impaired renal function. Patients with renal impairment should take a lower medication dosage in their age bracket. [36] Liver function and enzymes should be closely monitored in patients with hepatic impairment. Healthcare providers should make dosage adjustments as needed for patients with hepatic impairment. [37] Cetirizine may be confused with sertraline (look-alike-sound-alike drugs).\u00a0Clinicians and pharmacists should be careful while prescribing and dispensing this drug. [38]", "contents": "Cetirizine -- Monitoring. The kidney primarily excretes cetirizine; as a result, the risk of toxicity is typically higher in patients with impaired renal function. Patients with renal impairment should take a lower medication dosage in their age bracket. [36] Liver function and enzymes should be closely monitored in patients with hepatic impairment. Healthcare providers should make dosage adjustments as needed for patients with hepatic impairment. [37] Cetirizine may be confused with sertraline (look-alike-sound-alike drugs).\u00a0Clinicians and pharmacists should be careful while prescribing and dispensing this drug. [38]"}
{"id": "article-19266_29", "title": "Cetirizine -- Toxicity -- Animal studies", "content": "Studies using rat models\u00a0have shown the minimal lethal dose of cetirizine to be approximately 460 times the maximum recommended daily dose for adults. The primary target of acute toxicity in rodents was the central nervous system. The primary target of multiple-dose toxicity in rodents was the liver.", "contents": "Cetirizine -- Toxicity -- Animal studies. Studies using rat models\u00a0have shown the minimal lethal dose of cetirizine to be approximately 460 times the maximum recommended daily dose for adults. The primary target of acute toxicity in rodents was the central nervous system. The primary target of multiple-dose toxicity in rodents was the liver."}
{"id": "article-19266_30", "title": "Cetirizine -- Toxicity -- Signs and Symptoms of Overdose", "content": "A small number of cases of cetirizine overdose appear in the literature. However, many overdoses of cetirizine in children result from improper medication storage by adults living in the same home. Most overdose incidents in children resolve spontaneously, with drowsiness and sedation being the main adverse effects observed.\u00a0Drug-induced liver damage is common with numerous medications; there are reports of a small number of cases of cetirizine-induced liver damage. In all cases, liver enzyme values returned to normal after\u00a0cetirizine cessation. [39] An adult who overdosed on 150 mg cetirizine had somnolence but did not have abnormal blood chemistry, hematology results, or other clinical signs. An infant overdosed on\u00a0180 mg of cetirizine and experienced restlessness and irritability, followed by drowsiness.\u00a0Several hours after an accidental overdose of cetirizine, the 6-year-old\u00a0child presented with fixed and dilated pupils, tachycardia, agitation,\u00a0hyperthermia, and hallucinations consistent with anticholinergic toxicity. [40]", "contents": "Cetirizine -- Toxicity -- Signs and Symptoms of Overdose. A small number of cases of cetirizine overdose appear in the literature. However, many overdoses of cetirizine in children result from improper medication storage by adults living in the same home. Most overdose incidents in children resolve spontaneously, with drowsiness and sedation being the main adverse effects observed.\u00a0Drug-induced liver damage is common with numerous medications; there are reports of a small number of cases of cetirizine-induced liver damage. In all cases, liver enzyme values returned to normal after\u00a0cetirizine cessation. [39] An adult who overdosed on 150 mg cetirizine had somnolence but did not have abnormal blood chemistry, hematology results, or other clinical signs. An infant overdosed on\u00a0180 mg of cetirizine and experienced restlessness and irritability, followed by drowsiness.\u00a0Several hours after an accidental overdose of cetirizine, the 6-year-old\u00a0child presented with fixed and dilated pupils, tachycardia, agitation,\u00a0hyperthermia, and hallucinations consistent with anticholinergic toxicity. [40]"}
{"id": "article-19266_31", "title": "Cetirizine -- Toxicity -- Management of Overdose", "content": "There is no known specific antidote to cetirizine, and it\u00a0can not be effectively removed by dialysis. When overdosed on cetirizine, treatment should be supportive and symptomatic, considering any concomitantly ingested medications. [41]", "contents": "Cetirizine -- Toxicity -- Management of Overdose. There is no known specific antidote to cetirizine, and it\u00a0can not be effectively removed by dialysis. When overdosed on cetirizine, treatment should be supportive and symptomatic, considering any concomitantly ingested medications. [41]"}
{"id": "article-19266_32", "title": "Cetirizine -- Enhancing Healthcare Team Outcomes", "content": "Cetirizine\u00a0is a relatively safe and effective medication for treating allergic rhinitis, urticaria, and allergic conjunctivitis. As cetirizine is also available over the counter, prescribers should educate patients on the possible side effects, which include drowsiness,\u00a0fatigue, and dry mouth. Healthcare providers\u00a0should be careful when prescribing cetirizine to patients with impaired renal or hepatic function. Ophthalmologists\u00a0should educate contact lens wearers\u00a0on proper precautions and direct use of eye drops. Patients using eye drops should be informed that\u00a0local pain at the instillation site, ocular hyperemia, and decreased visual acuity are common adverse reactions with the ophthalmic formulation.", "contents": "Cetirizine -- Enhancing Healthcare Team Outcomes. Cetirizine\u00a0is a relatively safe and effective medication for treating allergic rhinitis, urticaria, and allergic conjunctivitis. As cetirizine is also available over the counter, prescribers should educate patients on the possible side effects, which include drowsiness,\u00a0fatigue, and dry mouth. Healthcare providers\u00a0should be careful when prescribing cetirizine to patients with impaired renal or hepatic function. Ophthalmologists\u00a0should educate contact lens wearers\u00a0on proper precautions and direct use of eye drops. Patients using eye drops should be informed that\u00a0local pain at the instillation site, ocular hyperemia, and decreased visual acuity are common adverse reactions with the ophthalmic formulation."}
{"id": "article-19266_33", "title": "Cetirizine -- Enhancing Healthcare Team Outcomes", "content": "Immunologists play a crucial role in the management of refractory urticaria. Nurses\u00a0should monitor therapeutic success and consult patients not to combine cetirizine with drugs that cause central nervous system depression. Pharmacists should perform regular and thorough medication\u00a0reconciliation and verify that the patient is not taking any medications or supplements that could exacerbate cetirizine's adverse effects. Clinicians (MDs, DOs, NPs, PAs), nurses, and pharmacists\u00a0who prescribe or recommend cetirizine to patients should also provide information on the safe storage of cetirizine to prevent accidental overdose by children. If\u00a0the overdose of cetirizine is intentional, a psychiatrist should be consulted. Communication and collaboration among interprofessional teams can achieve the best patient outcomes and reduce healthcare service utilization costs.", "contents": "Cetirizine -- Enhancing Healthcare Team Outcomes. Immunologists play a crucial role in the management of refractory urticaria. Nurses\u00a0should monitor therapeutic success and consult patients not to combine cetirizine with drugs that cause central nervous system depression. Pharmacists should perform regular and thorough medication\u00a0reconciliation and verify that the patient is not taking any medications or supplements that could exacerbate cetirizine's adverse effects. Clinicians (MDs, DOs, NPs, PAs), nurses, and pharmacists\u00a0who prescribe or recommend cetirizine to patients should also provide information on the safe storage of cetirizine to prevent accidental overdose by children. If\u00a0the overdose of cetirizine is intentional, a psychiatrist should be consulted. Communication and collaboration among interprofessional teams can achieve the best patient outcomes and reduce healthcare service utilization costs."}
{"id": "article-19266_34", "title": "Cetirizine -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Cetirizine -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}